Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03070938 · ClinicalTrials.gov registry record
PuraPly™ Antimicrobial Wound Matrix and Wound Management
A clinical trial of Surgical Wound and Venous Ulcer, sponsored by Organogenesis.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03070938 is a study of Surgical Wound and Venous Ulcer that has completed, run by Organogenesis. The registered enrollment target is 100 participants, above the 90-participant average among 17 other Surgical Wound trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03070938, a study of Surgical Wound and Venous Ulcer, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The PuraPly Antimicrobial Wound Matrix (PuraPly AM) case series is a prospective, observational study for patients who have received PuraPly AM which consists of a collagen sheet coated with polyhexamethylenbiguanide hydrochloride (PHMB) and is intended for the management of wounds; no experimental intervention is involved.
Conditions Studied
Interventions
- DEVICE PuraPly™ Antimicrobial Wound Matrix
Study Locations (1)
New York
- Winthrop University Hospital - Mineola
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03070938
The ClinicalTrials.gov registry entry for NCT03070938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 90-participant average among 17 other Surgical Wound trials with a reported enrollment target (11% higher). The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which PuraPly™ Antimicrobial Wound Matrix is the first listed.
NCT03070938 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03070938 about?
NCT03070938 is a clinical study titled "PuraPly™ Antimicrobial Wound Matrix and Wound Management". The PuraPly Antimicrobial Wound Matrix (PuraPly AM) case series is a prospective, observational study for patients who have received PuraPly AM which consists of a collagen sheet coated with polyhexamethylenbiguanide hydrochloride (PHMB) and is intended for the management of wounds; no experimental ...
What is the current status of trial NCT03070938?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2016-11. Estimated completion is 2017-10.
What conditions does trial NCT03070938 study?
This clinical trial studies the following conditions: Surgical Wound, Venous Ulcer, Pressure Ulcer, Trauma Wound, Diabetic Ulcer.
What interventions are being tested in trial NCT03070938?
The interventions under investigation include: PuraPly™ Antimicrobial Wound Matrix (DEVICE).
Who is sponsoring clinical trial NCT03070938?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03070938 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
-
Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
RECRUITING · NA
-
A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
RECRUITING
-
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
RECRUITING
-
Regenn® Therapy System Safety Study
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.